Microglia centered pathogenesis in ALS: insights in cell interconnectivity

Dora Brites1, Ana R Vaz1

  • 1Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa Lisbon, Portugal ; Department of Biochemistry and Human Biology, Faculdade de Farmácia, Universidade de Lisboa Lisbon, Portugal.

Insights

Amyotrophic lateral sclerosis (ALS) involves motor neuron (MN) degeneration, with glial cells like microglia playing complex roles. Understanding these cell interactions is key to developing new ALS therapies.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pathology

Background:

  • Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron (MN) disease of unknown cause.
  • While MN loss is central, non-cell-autonomous mechanisms involving glial cells are increasingly recognized.
  • Microglia exhibit dual roles, potentially protective early on but neurotoxic when activated.

Purpose of the Study:

  • To review the role of glial cells, particularly microglia, in ALS pathology.
  • To discuss the impact of neuroinflammation and microglial phenotypes on disease progression.
  • To explore intercellular communication disruptions and potential therapeutic targets in ALS.

Main Methods:

  • Review of existing literature and data from transgenic SOD1G93A rodent models.
  • Analysis of glial cell contributions (microglia, astroglia, oligodendrocytes, etc.) to ALS.
  • Examination of neuroinflammation, cell-cell communication, neurovascular disruption, and exosome trafficking.

Main Results:

  • Glial cells, especially microglia, significantly modulate ALS pathology through complex interactions.
  • Dysfunctional cell-cell communication, neuroinflammation, and neurovascular issues are implicated.
  • Both beneficial and harmful influences of various glial subtypes (NG2 cells, oligodendrocytes, Schwann cells) are observed.

Conclusions:

  • Intercellular perturbations are central to ALS pathogenesis.
  • Targeting these complex cell interactions and communication pathways offers potential for novel ALS therapeutics.
  • Further research into glial-neuronal cross-talk is crucial for effective disease management.